Compare NEOG & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEOG | WD |
|---|---|---|
| Founded | 1981 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 1995 | 2010 |
| Metric | NEOG | WD |
|---|---|---|
| Price | $9.51 | $51.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $10.67 | ★ $76.00 |
| AVG Volume (30 Days) | ★ 2.7M | 188.2K |
| Earning Date | 04-09-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.02 | ★ 1.64 |
| Revenue | $894,661,000.00 | ★ $1,234,306,000.00 |
| Revenue This Year | N/A | $20.60 |
| Revenue Next Year | N/A | $7.79 |
| P/E Ratio | $466.25 | ★ $30.84 |
| Revenue Growth | N/A | ★ 8.99 |
| 52 Week Low | $4.53 | $42.12 |
| 52 Week High | $11.43 | $90.00 |
| Indicator | NEOG | WD |
|---|---|---|
| Relative Strength Index (RSI) | 50.98 | 59.81 |
| Support Level | $8.98 | $48.44 |
| Resistance Level | $10.12 | $66.25 |
| Average True Range (ATR) | 0.36 | 1.49 |
| MACD | 0.00 | 0.35 |
| Stochastic Oscillator | 56.25 | 75.00 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.